Cameron Joyce MPA

Cameron is a Senior Policy Analyst at the Duke-Margolis Institute for Health Policy.

Cameron contributes to the Institute's biomedical innovation and evidence development portfolio. He supports the drug supply chain and drug shortages consortium with work focused on Advanced Manufacturing Technologies. He supports the Institute's policy research to combat drug-resistant infections and antimicrobial resistance (AMR) and other projects including work towards advancing clinical trials.

Cameron also has experience engaging in collaborative research and convening activities with the U.S. Food and Drug Administration (FDA) to advance regulatory science and the more efficient development of safe and effective drugs and medical products.